Mark A. Murcko
123 works · 16,617 citations · h-index 52
Top works
- Structure and mechanism of interleukin-lβ converting enzyme
- The Properties of Known Drugs. 1. Molecular Frameworks
- Virtual screening—an overview
- Can We Learn To Distinguish between “Drug-like” and “Nondrug-like” Molecules?
- Consensus Scoring: A Method for Obtaining Improved Hit Rates from Docking Databases of Three-Dimensional Structures into Proteins
- Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzyme
- The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase
- Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide
- Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding
- Evidence for the direct involvement of the rhinovirus canyon in receptor binding.
- Structure and Mechanism of Inosine Monophosphate Dehydrogenase in Complex with the Immunosuppressant Mycophenolic Acid
- Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field
- Computational Methods to Predict Binding Free Energy in Ligand-Receptor Complexes
- Properties of Known Drugs. 2. Side Chains
- Designing Libraries with CNS Activity
- Recognizing molecules with drug-like properties
- GroupBuild: a fragment-based method for de novo drug design
- Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma
- Prediction of ‘drug-likeness’
- The SHAPES strategy: an NMR-based approach for lead generation in drug discovery